tiprankstipranks
Rhythm Pharmaceuticals (RYTM)
NASDAQ:RYTM
US Market
Want to see RYTM full AI Analyst Report?

Rhythm Pharmaceuticals (RYTM) Technical Analysis

616 Followers

Technical Sentiment

Overall Consensus
Buy
11Bullish
3Neutral
8Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Rhythm Pharmaceuticals’s (RYTM) Moving Averages Convergence Divergence (MACD) indicator is 1.16, suggesting Rhythm Pharmaceuticals is a Buy.
Rhythm Pharmaceuticals’s (RYTM) 20-Day exponential moving average is 105.55, while Rhythm Pharmaceuticals’s (RYTM) share price is $88.69, making it a Sell.
Rhythm Pharmaceuticals’s (RYTM) 50-Day exponential moving average is 100.90, while Rhythm Pharmaceuticals’s (RYTM) share price is $88.69, making it a Buy.

Rhythm Pharmaceuticals (RYTM) Pivot Points

Jul 26, 2026, 01:00 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
99.08
100.06
101.36
102.34
103.64
104.62
105.92
Fibonacci
100.06
100.93
101.47
102.34
103.21
103.75
104.62
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Rhythm Pharmaceuticals (RYTM) Moving Averages

Jul 26, 2026, 01:00 PM
Period
Simple
Exponential
MA5
103.99Sell
103.89Sell
MA10
105.98Sell
105.51Sell
MA20
108.99Sell
105.55Sell
MA50
98.49Buy
100.90Buy
MA100
92.90Buy
97.85Buy
MA200
98.91Buy
98.98Buy
Rhythm Pharmaceuticals’s (RYTM) 10-Day exponential moving average is 105.51, while Rhythm Pharmaceuticals’s (RYTM) share price is $88.69, making it a Sell.
Rhythm Pharmaceuticals’s (RYTM) 100-Day exponential moving average is 97.85, while Rhythm Pharmaceuticals’s (RYTM) share price is $88.69, making it a Buy.
Rhythm Pharmaceuticals’s (RYTM) stock price is $88.69 and Rhythm Pharmaceuticals’s (RYTM) 50-day simple moving average is 98.49, creating a Buy signal.
Rhythm Pharmaceuticals’s (RYTM) stock price is $88.69 and Rhythm Pharmaceuticals’s (RYTM) 100-day simple moving average is 92.90, creating a Buy signal.
Rhythm Pharmaceuticals’s (RYTM) stock price is $88.69 and Rhythm Pharmaceuticals’s (RYTM) 200-day simple moving average is 98.91, creating a Buy signal.

Rhythm Pharmaceuticals (RYTM) Technical Indicators

Jul 26, 2026, 01:00 PM
Name
Value
Implied Action
RSI (14)
45.21
Neutral
STOCH (9,6)
11.55
Buy
STOCHRSI (14)
8.12
Buy
MACD (12,26)
1.16
Buy
ADX (14)
27.96
Neutral
Williams %R
-92.88
Buy
CCI (14)
-133.29
Buy
ATR (14)
4.16
-
Ultimate Oscillator
44.05
Neutral
ROC
-8.58
Sell
Rhythm Pharmaceuticals’s (RYTM) Relative Strength Index (RSI) is 45.21, creating a Neutral signal.
Rhythm Pharmaceuticals’s (RYTM) Trend Strength Indicator (ADX) is 27.96, creating a Neutral signal.
Rhythm Pharmaceuticals’s (RYTM) Commodity Channel Index (CCI) is -133.29, creating a Buy signal.
Rhythm Pharmaceuticals’s (RYTM) Price Rate of Change (ROC) is -8.58, creating a Sell signal.

FAQ

Is RYTM a Buy, Hold, or Sell?
Based on RYTM’s technical indicators, RYTM is a Buy.
    What is RYTM’s RSI (14)?
    RYTM’s RSI (14) is 45.21, which suggests RYTM is a Neutral.
      What is RYTM’s MACD?
      RYTM’s MACD is 1.16, which suggests RYTM is a Buy.
        What is RYTM’s 5-day moving average?
        RYTM’s 5-day moving average is 103.99, which suggests RYTM is a Sell.
          What is RYTM’s 20-day moving average?
          RYTM 20-day moving average is 108.99, which suggests RYTM is a Sell.
            What is RYTM’s 50-day moving average?
            RYTM’s 50-day moving average is 98.49, which suggests RYTM is a Buy.
              What is RYTM’s 200-day moving average?
              RYTM’s 200-day moving average is 98.91, which suggests RYTM is a Buy.
                What is RYTM’s Williams % R (14)?
                RYTM’s Williams % R (14) is -92.88, which suggests RYTM is a Buy.
                  What is RYTM’s CCI (14)?
                  RYTM’s CCI (14) is -133.29, which suggests RYTM is a Buy.